NO20065800L - IL-13 bindingsmidler - Google Patents
IL-13 bindingsmidlerInfo
- Publication number
- NO20065800L NO20065800L NO20065800A NO20065800A NO20065800L NO 20065800 L NO20065800 L NO 20065800L NO 20065800 A NO20065800 A NO 20065800A NO 20065800 A NO20065800 A NO 20065800A NO 20065800 L NO20065800 L NO 20065800L
- Authority
- NO
- Norway
- Prior art keywords
- binding agents
- mediators
- modulate
- receptors
- antibodies
- Prior art date
Links
Landscapes
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
SAMNIENDRAG Midler (for eksempel antistoffer og fragmenter derav) som binder spesifikt til IL-13 og modulerer evnen av IL-13 til å interagere med IL-13-reseptorer og mediatorer for signalering er beskrevet.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58107804P | 2004-06-17 | 2004-06-17 | |
PCT/US2005/021454 WO2006085938A2 (en) | 2004-06-17 | 2005-06-17 | Il-13 binding agents |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20065800L true NO20065800L (no) | 2007-01-17 |
Family
ID=36838629
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20065800A NO20065800L (no) | 2004-06-17 | 2006-12-14 | IL-13 bindingsmidler |
Country Status (4)
Country | Link |
---|---|
CN (1) | CN101432018A (no) |
AR (2) | AR049355A1 (no) |
NO (1) | NO20065800L (no) |
TW (1) | TW200610768A (no) |
-
2005
- 2005-06-16 AR ARP050102481 patent/AR049355A1/es unknown
- 2005-06-17 TW TW094120296A patent/TW200610768A/zh unknown
- 2005-06-17 CN CNA2005800246871A patent/CN101432018A/zh active Pending
-
2006
- 2006-12-14 NO NO20065800A patent/NO20065800L/no not_active Application Discontinuation
-
2010
- 2010-08-17 AR ARP100103009 patent/AR077930A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN101432018A (zh) | 2009-05-13 |
AR049355A1 (es) | 2006-07-19 |
AR077930A2 (es) | 2011-10-05 |
TW200610768A (en) | 2006-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG166090A1 (en) | Il-13 binding agents | |
CY1121208T1 (el) | Σκευασματα αντισωματος ναταλιζουμαμπης | |
ME00261B (me) | Tweak vezujuća antitijela | |
NO2017032I1 (no) | bezlotoksumab | |
NO20076046L (no) | Bindemidler | |
PH12016501691A1 (en) | Antibodies to matrix metalloproteinase 9 | |
MX2009008104A (es) | Hepcidina, antagonistas de hepcidina y metodos de uso. | |
NO20092652L (no) | Konstruert anti-TSLP-antistoff | |
GEP20125612B (en) | Prlr-specific antibody and usage thereof | |
MY174493A (en) | Binding agents | |
DK1778236T3 (da) | Modificerede pyrimidin-glucocorticoid-receptor-modulatorer | |
DK1836169T5 (da) | Sammensætninger og fremgangsmåder til behandling af celleproliferationslidelser | |
WO2006118772A3 (en) | Fcrn antibodies and uses thereof | |
NO20091926L (no) | Anti-Notch3-agonist-antistoffer og deres anvendelse ved behandlingen av Notch3-relaterte sykdommer | |
EA201000717A1 (ru) | Молекулы и способы, предназначенные для модуляции компонента системы комплемента | |
MXPA06014754A (es) | Compuestos y metodos para inhibir la interaccion de las proteinas bcl con los componentes de enlace. | |
DK1742966T3 (da) | Antistoffer og molekyler afledt deraf som binder til STEAP-1 proteiner | |
NO20061412L (no) | Terapi av okulaere foretyrrelser | |
NO20065252L (no) | Behandling av forstyrrelser | |
MX2007004247A (es) | Agentes de aglutinacion especifica a angiopoyetina-2. | |
MX2009004167A (es) | Anticuerpos que enlazan epitopos cxcr7. | |
TW200745159A (en) | IL-6 binding proteins | |
NO20074277L (no) | Kinnolinforbindelser og anvendelse derav som lever X reseptor modulatorer | |
DK1987357T3 (da) | Polypeptider, som genkendes af anti-Trichinella-antistoffer, og anvendelser deraf | |
NO20065800L (no) | IL-13 bindingsmidler |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |